Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 02/12/2011
PIL Zypadhera 210mg, 300mg and 405mg powder and solvent for prolonged release suspension for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 03/11/2011 and displayed until 02/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 03/02/2011 and displayed until 03/11/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 28/10/2010 and displayed until 03/02/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 19/01/2010 and displayed until 28/10/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 12/08/2009 and displayed until 19/01/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to storage instructions
Updated on 11/02/2009 and displayed until 12/08/2009
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 26/01/2009 and displayed until 11/02/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  Olanzapine Pamoate Monohydrate